![](/img/cover-not-exists.png)
P-550 Phase 1–2 dose-ranging trial of TLK286 (TELCYTA) and Cisplatin (C) as first-line treatment in advanced non-small cell lung cancer (NSCLC)
Papadimitrakopoulou, V., Edelman, M., Zinner, R., Blumenschein, G., Jones, S., Willcutt, N., Keck, J., Brown, G., Burris, H.Volume:
49
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/s0169-5002(05)81043-8
Date:
July, 2005
File:
PDF, 134 KB
english, 2005